Quality of care of patients hospitalized with acute coronary syndromes

Internal Medicine Journal

Volumn 32, Issue 11, 2002, Pages 502-511

  Scott, I A ^a,b   Denaro, C P ^b,c   Flores, J L ^d   Bennett, C J ^c   Hickey, A C ^a   Mudge, A M ^c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d Queen Elizabeth II Hospital   (Australia)

Author keywords

Acute coronary syndromes; Indicators; Quality of care

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIPID;

ACUTE DISEASE; ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD CLOT LYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEALTH CARE QUALITY; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK ASSESSMENT; TEACHING HOSPITAL;

AGED; ANGINA, UNSTABLE; CARDIOLOGY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; MALE; MEDICAL AUDIT; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; QUEENSLAND; SYNDROME; THROMBOLYTIC THERAPY;

EID: 0036402423     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00267.x     Document Type: Article

References (29)

1. Commonwealth Department of Health and Aged Care and Australian Institute of Health and Welfare. National Health Priority Areas Report: Cardiovascular Health AIHW Cat, no. PHE. 9. Canberra: HEALTH and AIHW; 1998.
2. Aroney C, Boyden AN, Jelinek MV, Thompson P, Tonkin AM, White H. on behalf of the Unstable Angina Working Group. Management of unstable angina guidelines - 2000. Med J Aust 2000; 173: S65-88.
3. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2000; 36: 970-1062.
4. British Cardiac Society. Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation: British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit. Heart 2001; 85: 133-42.
5. Quality of Care and Outcomes Research in CVD and Stroke Working Groups. Measuring and improving quality of care. A report from the AHA/ACC First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. Circulation 2000; 101: 1483-93.
6. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT et al. Treatment of myocardial infarction in the United States (1990-93): Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103-14.
7. Krumholz HM, Murillo JE, Chen J, Vaccarino V, Radford MJ, Ellerbeck EF et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997; 277: 1683-8.
8. Krumholz HM, Radford MJ, Ellerbeck EF, Hennen J, Meehan TP, Petrillo M et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes. Circulation 1995; 92: 2841-7.
9. Krumholz HM, Radford MJ, Wang Y, Chen J, Marciniak TA. Early beta-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med 1999; 131: 648-54.
10. Barron HV, Michaels AD, Maynard C, Every NR for the National Registry of Myocardial Infarction 2 Participants. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the NRMI 2. J Am Coll Cardiol 1998; 32: 360-7.
11. Majumdar SR, Gurwitz JH, Soumerai SB. Undertreatment of hyperlipidaemia in the secondary prevention of coronary artery disease. J Gen Intern Med 1999; 14: 711-7.
12. King KM, Humen DP, Teo KK. Cardiac rehabilitation: the forgotten intervention. Can J Cardiol 1999; 15: 979-85.
13. Scott IA. The Brisbane Cardiac Consortium Clinical Support Systems Project. Fellowship Affairs 2000; 19: 23. Details available at: http://www.health.qld.gov.au/BCC.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
15. National Health and Medical Research Council. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra: National Health and Medical Research Council; 1999.
16. McNamara KS, Peterson GM, Friesen WT. Changes in the management of acute myocardial infarction in southern Tasmania. J Clin Pharm Ther 2000; 25: 111-8.
17. Fonarow GC, French WJ, Parsons LS, Sun H, Malmgren JA, for the National Registry of Myocardial Infarction 3 (NRMI-3) Participants. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction. Data from the National Registry of Myocardial Infarction 3. Circulation 2001; 103: 38-44.
18. Mehta RH, Das S, Tsai TT, Nolan E, Kearly G, Eagle KA et al. Quality improvement initiative and its impact on the management of patients with acute myocardial infarction. Arch Intern Med 2000; 160: 3057-62.
19. Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J et al., for the GAP Steering Committee of the American College of Cardiology. Improving quality of care for acute myocardial infarction. The Guidelines Applied in Practice (GAP) Initiative. JAMA 2002; 287: 1269-76.
20. Australian Council on Health Care Standards. Measurement of Care in Australian Hospitals, 5th edn. Melbourne: Australian Council on Healthcare Standards; 1998.
21. Palmer DJ, Cox KL, Dear K, Leitch JW. Factors associated with delay in giving thrombolytic therapy after arrival at hospital. Med J Aust 1998; 168: 111-4.
22. Bunker S, McBurney H, Cox H, Jelinek M. Identifying participation rates at outpatient cardiac rehabilitation programs in Victoria, Australia. J Cardiopulm Rehab 1999; 19: 334-8.
23. Pilote L, Miller DP, Califf RM, Rao JS, Weaver WD, Topol EJ et al. Determinants of the use of coronary angiography and revascularisation after thrombolysis for acute myocardial infarction. N Engl J Med 1996; 335: 1198-205.
24. Holden JD. Hawthorne effects and research into professional practice. J Eval Clin Pract 2001; 7: 65-70.
25. Lescoe-Long M, Long MJ. Defining the utility of clinically acceptable variations in evidence-based practice guidelines for evaluation of quality improvement activities. Eval Health Prof 1999; 22: 298-324.
26. Marciniak TA, Ellerbeck EF, Radford MJ, Kresowick TF, Gold JA, Krumholz HM et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA 1998; 279: 1351-7.
27. Soumerai SB, McLaughlin TJ, Gurwitz JH, Guadagnoli E, Haupman PJ, Borbas C et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA 1998; 279: 1358-63.
28. Robinson MB, Thompson E, Black NA. Evaluation of the effectiveness of guidelines, audit and feedback: improving the use of intravenous thrombolysis in patients with suspected acute myocardial infarction. Int J Quality Health Care 1996; 8: 211-22.
29. Scott IA, Coory MD, Harper CM. The effects of quality improvement interventions on inhospital mortality following acute myocardial infarction. Med J Aust 2001; 175: 465-70.